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Veronika Bachanova, Valarie McCullar, Todd Lenvik, Rosanna Wangen, Karen A. Peterson,
Dave EM. Ankarlo, Angela Panoskaltsis-Mortari, John E. Wagner, Jeffrey S. MillerNatural Killer (NK) cells are powerful effectors of cytotoxicity against ‘‘stressed’’ cells. They also produce
cytokines and chemokines to activate the adaptive immune response. Understanding NK cell development
and maturation may have implications for cancer therapy and for immunity against infections. We hypothe-
sized that Notch signaling, critical for hematopoesis, would be involved in NK cell development. The role of
constitutively activated Notch1 (ICN) on NK cell maturation was studied using human umbilical cord blood
(UCB) progenitors cultured on a murine embryonic liver stroma cell line (EL08-1D2) and human cytokines.
UCB CD341/ICN1 sorted cells resulted in a population of CD71 early lymphoid precursors and subsequent
NK lineage commitment independent of stroma or IL-15. Early expression of L-selectin on ICN1 precursors
suggested their homing competence. These precursors further committed to the NK lineage, and were
capable of producing cytokines and chemokines such as interkeukin (IL)-13, granulocyte macrophage-colony
stimulating factor (GM-CSF), tumor necrosis factor-alpha (TNF-a), yet poorly acquired NK inhibitory recep-
tors and cytotoxic effector function. In the presence of stroma, ICN1 precursors also gave rise to a popula-
tion of early T lineage committed cells characterized by expression of cytoplasmic CD3 g, e, and d chains,
RAG1/2, and production of IL-2, suggesting bona fide Th1 commitment. Importantly, signals from EL08-1D2
stroma were required for this development process. In conclusion, sustained Notch signaling can replace
stroma in differentiation of a common CD71 lymphoid precursor from UCB CD341 progenitors and induce
NK cell commitment. However, these NK cells are immature in their cytokine production profile, are hypo-
responsive, and poorly acquire NK cell receptors involved in self-tolerance and effector function.
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Natural killer (NK) cells defined by CD56 expres-
sion and the absence of CD3 comprise 10% to 15% of
peripheral blood lymphocytes. They also reside in the
spleen, bone marrow, lymph nodes, liver, intestines,
and the pregnant uterus. NK cells can eliminate
infected or cancer-transformed cells in the absence of
antigen-specific receptors [1]. In order to protect
healthy tissues, NK cells are under a constant inhibi-Division of Adult and Pediatric Hematology, Oncology,
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6/j.bbmt.2008.11.031tion delivered by engagement of inhibitory receptors,
which recognize ‘‘self’’ class 1 human leukocyte anti-
gens (HLA) [2]. Multiple inhibitory receptors such as
killer immunoglobulin receptors (KIR) and CD94/
NKG2 heterodimers are stochastically expressed dur-
ing NK cell development in a regulated sequential
fashion until each individual NK cell is ‘‘licensed’’ by
recognition of at least 1 inhibitory receptor by its cog-
nate HLA ligand [3,4]. In this process NK cells
become functionally competent. Their ability to kill
is determined by net signals from their inhibitory
(KIR, NKG2A, and others) and activating receptors
(NKG2D, natural cytotoxicity receptors). Recently,
a population of circulating CD56dim NK cells has
been found in normal volunteers that lack KIR and
NKG2A but are hyporesponsive or globally anergic
linking expression of receptors to the acquisition of
effector function [5].
In contrast to peripheral blood CD56dimCD3–
cytotoxic NK cells the population of ‘‘regulatory’’
CD56brightKIR– NK cells resides in secondary lym-
phoid tissues and coexpress receptors for inflammatory183
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tin) and CCR7 [6]. They are highly proliferative and
secrete interferon (IFN)-g, interleukin 10 (IL 2-10),
2 IL-13, and granulocyte macrophage-colony stimu-
lating factor (GM-CSF) in response to IL-12/IL-18
stimulation. Their immunoregulatory functions syn-
ergize with adoptive immune responses [7]. Lymphoid
progenitors CD341CD45RA1integrin b7
1 isolated
from human lymph nodes are capable of differentia-
tion into CD56bright NK cells [8]. The process by
which NK cells and their subsets differentiate and ma-
ture has important implications for reconstitution after
hematopoietic cell transplantation and cancer therapy
[9-11].
In humans, NK cell development from hemato-
poetic stem cells has been studied using stromal and
nonstroma-based cultures [12-17]. NK cells derived
from CD341/Lin– primitive progenitors can develop
in the bone marrow microenvironment. Surface ex-
pression of CD7 is an early event in lymphoid commit-
ment and NK cell differentiation [12] and all mature T
and NK lymphocytes continue to express CD7. We
have shown that human bone marrow and cord blood
CD341 progenitors effectively differentiate into NK
cells when cultured with the murine stroma cell lines
AFT024 or EL08-1D2. These cultures not only in-
duce NK cell development but also support the acqui-
sition of KIR and NKG2A, vital steps preceding
‘‘licensing’’ [15,17]. In addition to direct contact be-
tween hematopoetic cell and their microenviroment,
NK cell commitment requires the presence of human
cytokines [13].
One conserved mechanism to regulate cell-to-cell
interactions, proliferation, and differentiation is
through Notch signaling [19,20]. Notch 1 triggers
CD7 expression on hematopoetic progenitors in vitro,
and has been shown to regulate early lymphoid devel-
opment and commitment toward the T and NK line-
age [21]. Recent mouse and human data suggest that
transient Notch signaling can be permissive to NK
commitment [22,23], yet the effect of Notch signaling
on NK cell maturation and function is still not well
understood.
The Notch ligands Delta and Jagged are trans-
membrane proteins expressed in tissues such as bone
marrow stroma, thymus, and lymphoid organs, which
trigger Notch receptors (1, 2, 3, and 4) on the surface
of hematopoetic cells [22,23]. After binding to the
ligand, intracellular Notch (ICN) [24,25] is released
in a series of proteolytic cleavages and migrates into
the nucleus to displace corepressors from the CSL
(CBF1/Suppressor of Hairless/Lag-1) protein. This
further recruits a coactivator from the mastermind
family (MAML) and converts the complex into
a DNA binding transcription factor to target genes
such as HES (Hairy Enhancer of Split) family mem-
bers [27]. Given the dynamic changes that occur inmodels to recapitulate NK cell maturation, we chose
to overexpress constitutively activated Notch1 in he-
matopoietic progenitors as a ‘‘constant on signal’’ to
better understand its function inNK cell development.
Our results show that activated Notch alone is suffi-
cient for development of early lymphoid precursors,
which are capable of differentiation into KIR2, poorly
cytotoxic, cytokine producing CD561CD3– NK cells
that are not fully mature.METHODS
Cell Isolation
Umbilical cord blood (UCB) was obtained from
full-term deliveries from the Memorial Blood Bank
(Minneapolis, MN) or the New York Blood Bank.
The committee on the Use of Human Subjects in
Research at the University of Minnesota approved
the use of all tissue. Mononuclear cells were separated
using Ficoll-Hypaque (sp.grav.1.077 Sigma Diagnos-
tics, St. Louis, MO) density gradient centrifugation.
CD341 progenitor cells were isolated by double posi-
tive selection with magnetic bead (Miltenyi Biotech,
Oberlin, CA) column separation (MACS) resulting in
a purity of .95%. CD341 cells were plated in 6-well
plates and cultured in media (Iscove’s modified Dul-
becco’s medium) supplemented with 20% bovine calf
serum, 100 U/mL penicillin, 100 U/mL streptomycin
(Gibco, Gaithersburg, MD), and exogenous cytokines
c-kit ligand (c-kit-L), Flt3-ligand (Flt3-L), IL-7, and
thrombopoietin (TPO) (all at 20 ng/mL) for 48 hours.
Following preactivation of these cytokines, retroviral
transduction was performed (described below). Trans-
duced cells were harvested and stained with anti
CD34-APC monoclonal antibody (BD Biosciences,
San Jose, CA) and sorted for CD341/GFP1 cells to
.98 % purity using a fluorescence activated cell sorter
(FACS) DiVa or Aria (Becton Dickinson, San Jose,
CA).Retroviral Transduction
Constructs were transiently transfected into 293kj
cells (a kind gift from Dr. M. Haas, University of Cal-
ifornia, San Diego) with PCL plasmid and Mig-R-
based retroviral vectors encoding the intracellular
domain of human Notch1 (ICN) tagged with green
fluorescent protein from a bicistronic transcript (gift
from Dr. W. Pear, University of Philadelphia, Penn-
sylvania) [28], and eGFP empty vector control
(eGFP). We confirmed positive fluorescence and
obtained viral supernatants after 48 and 72 hours as de-
scribed [29]. Following preactivation UCB CD341
progenitors were transduced twice, 24 hours apart,
with 3 mL of supernatant containing eGFP and ICN
Biol Blood Marrow Transplant 15:183-194, 2008 185Notch in Human NK Cell Developmentretrovirus in Fibronectin (Retronectin, Tarka)-coated
transwells at a density of 300,000 cells/well [30].
Culture of Hematopoietic Progenitors
Postdouble column purified nonmanipulated
CD341 cells, CD341ICN1 and CD341eGFP1 trans-
duced and sorted cells were suspended at density of 50-
100 cells/well on 96W plates (Costar, Cambridge,
MA) without stroma or on plates preestablished with
a murine embryonic liver cell line EL08-1D2 irradi-
ated (3000 cGy) prior to culture. CD341 progenitors
were cultured inmedia containing 2:1mix of Dulbecco
modified Eagle medium (DMEM, high glucose with-
out sodium pyruvate)/Ham F12-based medium
(Gibco Laboratories, Grand Island, NY) and supple-
mented with 24 mM 2-mercaptoethanol, 50 mM etha-
nolamine, 20 mg/L ascorbic acid, 50 mg/L sodium
selenite, 100 U/mL penicillin, 100 U/mL streptomy-
cin (Gibco), 20% heat-inactivated human AB serum
(Valley Biomedical, Inc., Winchester, VA). Human
cytokines (10 ng/mL Flt3-L, 20 ng/mL IL-7, 20 ng/
mL c-kit-L, 5 ng/mL IL-3 with or without 10 ng/
mL IL-15) (all from R&D Systems, Minneapolis,
MN) were supplemented weekly except for IL-3,
which was used once at culture initiation. Cultures
were re-fed weekly with 50% volume changes. Plates
were maintained in a humidified atmosphere of 5%
CO2 at 37
C.
Antibodies, Proliferation
Cultured cells were stained with: APC-conjugated
monoclonal antibodies against CD34 (8G12), CD56
(NCAM 16.2), CD8 (SK1), CD44 (G44-26), CD3
(SK7), CD94; PE-conjugated monoclonal antibodies
against CD7 (M-T701), CD4 (SK3), CD45RA
(HI100), CD62L (Dreq56), CD117 (104D2), CD25
(M-A251), NKG2A (Z199), CD158a (EB6), CD158b
(GL183), CD158e (NKB1, DX9), CD158i
(KARp50.3, FES172), NKG2D (ON72), NKp30
(Z25), NKp44 (Z231), NKp46 (BAB281), T cell
receptor (TCR) a/b (T10B9.IA-31), TCR g/d (B1),
and PerCP conjugated antibodies against CD3 (SK7)
and CD34 (8G12). Intracellular proteins were ana-
lyzed using monoclonal antibodies against CD3
(SK7), interferon-g (B27), IL-2 (5344.111), and per-
forin (dG9) (all PE). Appropriate fluorochrome-conju-
gated, isotype matched control Igs were used in all
experiments. All antibodies were from Beckman Coul-
ter (Fullerton, CA), BD Pharmigen (San Diego, CA),
or BD Biosciences. Flow cytometry data was acquired
using a FACS Calibur (Becton Dickinson) and ana-
lyzed using Flow-Jo software (Tree Star Inc., Ashland,
OR). The absolute number of NK cells were deter-
mined by adding 30,000 polystyrene microspheres
(Polysciences, Warrington, PA) to each aliquot and
calculated as previously described [12].Cytokine Production, Cytotoxicity Assays, and
Statistical Analysis
Cultured progeny of UCB CD341ICN1 and
CD341eGFP1 cells were harvested at day 28 and sus-
pended at a concentration of 1  106 cells/mL. Cyto-
kine production was tested after stimulating cells with
IL-12 (10 ng/mL) and IL-18 (100 ng/mL) for 18 hours
or in the presence of phorbol ester and calcium iono-
phore (PMA/ionomycin) for 5 hours. Cell-free super-
natants were analyzed by a 22-plex Luminex assay for
cytokine and chemokine protein concentrations as rec-
ommended by the manufacturer. Before staining for
intracellular perforin, IFN-g, and IL-2, Brefeldin A
was added to cultures in the last 5 hours of the incuba-
tion and cells were permeabilized using cytofix/cyto-
perm (BD Biosciences). Day 28 cells were tested in
4-hour 51Cr release cytotoxicity assay against the NK
sensitive target K562. Effector to target ratios ranged
from 0.082:1 to 20:1. All assays were performed in trip-
licate and percentage lysis was calculated as previously
described [31].
All results were reported from multiple indepen-
dent experiments (n) as the mean6 SEM. Significance
levels were determined by 2-sided Student t-test.Quantitative Reverse Transcriptase-Polymerase
Chain Reaction (Q-RT-PCR) Analysis and PCR
Total RNA isolated from cultured unmanipulated
cells at day 28 using RNAeasy Mini Kit (Qiagen, Santa
Clarita, CA) was converted to cDNAusing Superscript
II kit (Invitrogen, Carlsbad, CA). The cDNA product
was mixed with forward and reverse primers and
SYBRGreen PCR Master Mix (Applied Biosystems,
Foster City, CA) and Q-RT- PCR was performed
and analyzed on an ABI Prism 7900. Relative Quanti-
ties were normalized for Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) expression and compared to
the mRNA ratio in eGFP1 control cells. We designed
all primer sequences to span 2 exons to eliminate inter-
ference from genomic DNA using Primer3 software
(http://frodo.wi.mit.edu/cgibin/primer3/primer3_www.
cgi).
Primer sequences for ICN: AGGATCTCTCGA
GGT TAA CGA A (forward [fw]), GAC GGC AAT
ATG GTG GAA A (reverse [rs]); Hes1: GGA AAT
GAC AGT GAA GCA CCT (fw), GTC ACC TCG
TCC ATG CAC TC (rs); Hes5: CAG CAT CGA
GCA GCA GCT GAA (fw), TAG TCC TGG TGC
TGC AGG CTC TT (rs); GATA-3: GTC CTG
TGC GAA CTG TCA GA (fw), TTT TTC GGT
TTC TGG TCT GG (rs); preTa: AGA GGC TTC
TAC AGC CAG GAC (fw), AAA CAG CAG CAG
CTT GAA GAG (rs); RAG1: AAT ATC AAC CAA
ATT GCA GAC ATC(fw) GCA GAA CTG AGT
CCC AAG GT (rs); RAG2: ATT CAG AGA GGC
GTG AGC A (fw), CCT GGC TGA ATT AAG
186 Biol Blood Marrow Transplant 15:183-194, 2008V. Bachanova et al.GCT ATG T (rs). CD3 chains and CD127 reactions
used previously published primers.RESULTS
Notch1 Activation in UCB CD341 Progenitors
Generates a Population of CD71 Early
Lymphoid Precursors
To investigate the effect of cell-to-cell interactions
on differentiation, growth, and function of NK cells,
human UCB CD341 progenitors were cultured in di-
rect contact with the murine embryonic liver cell line
EL08-1D2. In the presence of exogenous human cyto-
kines (IL-7, IL-15, Flt3-L, c-kit-L, and IL-3) this
model powerfully recapitulates lymphoid differentia-
tion toward the NK cell lineage [15,32]. In the absence
of EL08-1D2 stroma virtually no NK cells (62 6 27)
developed from 10 starting progenitors compared to
58,510 6 4887 NK cells (P \ .0001) when stroma
was present, showing the requirement for contact
between hematopoietic progenitors and their support-
ive microenvironment. To study whether the Notch
pathway plays a role in NK differentiation, we overex-
pressed intracellular Notch1 (ICN) and an eGFP-
empty vector (eGFP) in UCB CD341 progenitors
and compared them in NK differentiation culture.
There were no phenotype or functional differences
between NK cell progeny transduced with the eGFP
control vector and untransduced CD341 cells (data
not shown). To ensure the integrity of transduced
genes, we demonstrated a 4.4-fold increase in ICN
mRNA levels and increased expression of downstreamFigure 1. Notch1 induces CD7 on CD341UCB progenitors. UCB CD341 pr
ence of c-kit-L, Flt3-L, IL-7, and TPO with MSCV-based eGFP and ICN vecto
embryonic liver stroma cell line EL08-1D2 with IL-3, c-kit-L, Flt3-L, IL-7, and
from cultured ICN1 cells (-) and eGFP1 cells was analyzed by Q-RT- PCR
Hes1 and Hes5 are relative to the level of GAPDH as a control for RNA integ
pression6 SEM of 3 independent experiments. (B) ICN1 and eGFP1 control
1D2 stroma and cytokines (IL-3, c-kit-L, Flt3-L, IL-7, and IL-15) for 7 additiona
Only ICN1 cell gave rise to a population of CD341CD71cells, which subse
lymphoid precursors.Notch transcripts HES1 (15-fold) and HES5 (515-
fold) in CD341ICN1 cells compared to CD341
eGFP1 cells (Figure 1A).
CD341ICN1 and CD341eGFP1 progenitors
were tested for CD7 expression immediately following
the transduction prior to any contact with EL08-1D2
stroma or exposure to IL-15. There was rapid acquisi-
tion of CD7 in ICN1 cells compared to essentially no
expression in the eGFP1 vector control (Figure 1B;
P 5 .05). The rapid and marked effect of ICN on
CD7 expression prior to culture with stroma suggests
that Notch1 signals are strong enough that they obvi-
ate the need for and can replace the requirement for
stroma to induce early NK cell development. In con-
trast to CD341 eGFP control cells, all CD341ICN1
cells lost the CD34 marker early in culture to become
CD342CD71 precursors (Figure 1B).
Activated Notch1 Increased Expression
of CD62L (L-Selectin) and CD45RA on UCB
CD341 Lymphoid Precursors
Fresh UCB-derived CD341 progenitors express
a low level of L-selectin and CD45RA (Figure 2, top
row). After 7 days of culture with EL08-1D2 stroma,
a significant population of CD341ICN1-derived cells
expressed both L-selectin (60% 6 9%) and CD45RA
(45% 6 8%), respectively, a level significantly higher
than the eGFP empty vector control-derived cells.
The expression of L-selectin and CD45RA was depen-
dent on the presence of EL08-1D2 stroma, and was
reduced in its absence (ICN1CD45RA1 9.9%;
ICN1CD62L1 4.4%; data not shown), suggesting
that stroma mediates additional signals, which areogenitors were transduced in Fibronectin-coated transwells in the pres-
rs, FACS sorted for CD341eGFP1 cells, plated in contact with murine
IL-15, and cultured for 28 days. (A) The induction of specific mRNA
. Relative transcripts of Notch1 (ICN) and downstream ICN targets
rity and reported as a ratio to eGFP controls. Bars represent mean ex-
cells were analyzed 2 days after transduction or after culture with EL08-
l days. All flow cytometry plots were gated on eGFP1 lymphocyte gate.
quently differentiated into CD342CD71 (and predominantly CD562)
Figure 2. Activated Notch1 induced early expression of CD45RA and the adhesion marker L-selectin (CD62L). Expression of CD62L and CD45RA on
fresh CD341 UCB progenitors is shown in the top row. CD341eGFP1 and CD341ICN1 progenitors cultured with EL08-1D2 stroma and cytokines
(Flt3-L, IL-7, c-kit-L, IL-15, and IL-3) for 7 days exhibited higher L-selectin and CD45RA expression compared to CD341eGFP1 (representative of 4
independent experiments).
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tested these NK cell intermediates for important
developmental antigens [33]. After 1 week, the prog-
eny of CD341ICN1 cultured cells expressed higher
levels of CD25 compared to CD341eGFP1 cells.
ICN1 and eGFP1 precursors fromNK cell differenti-
ation cultures expressed high levels of CD117 and
were negative for surface expression of CD10, CD1a,
IL-7Ra, CD122, CD16, CD94, or CD161, whereas
expression of LFA-1 and CD44 was heterogeneous
and not significantly different between ICN1 and
eGFP1 control starting populations (data not shown).
CD341ICN1-Derived Cells Have a Capacity
to Differentiate into CD71CD561CD32 NK
Cells
In the next set of experiments, we followed cells for
longer culture intervals on stroma to study NK cell
commitment and further maturation. Notably,
CD341ICN1 derived CD342CD71 precursors rap-
idly developed into CD561CD32NK cells, compared
to weak CD56 acquisition on CD341eGFP1 cells at
day 7, 14, or 21 (Figure 3A). By day 28, CD561CD32
NK cell development was present in both conditions,
although CD7 expression was homogeneously high
only on ICN1 cells (Figure 3B). The kinetics of
CD341ICN1-derived NK cells were significantly dif-
ferent from eGFP control cells (P\ .0005 at day 21,
Figure 3A).Activated Notch1 Renders NK Cells
Functionally Immature and Inhibits KIR
Acquisition
Given that UCB CD341 progenitors overexpress-
ing Notch1 can efficiently commit to the NK cell lin-
eage, we next asked whether they could acquire KIR,
cytotoxicity, and produce cytokines, all characteristics
of matureNK cells. In cytotoxicity assays against K562
cells ICN1 NK cells exhibited a significant reduction
in killing, whereas eGFP1 control-derived NK cells
effectively lysed targets (eGFP1 63% 6 2.9% versus
ICN1 44% 6 18%; n 5 7, P 5 .04; Figure 4A). The
mechanism of NK cell killing involves exocytosis of
perforin and granzyme containing cytoplasmic gran-
ules [34]. Staining for intracellular perforin expression
revealed a 2.5-fold reduction in ICN1 NK cells com-
pared to eGFP1-derived NK cells (eGFP1 56.2% 6
6% versus ICN1 19 6 1.5%, n 5 4, P 5 .01;
Figure 4B). In addition to target lysis, NK cells exert
regulatory functions through cytokines and chemo-
kines [35]. We stimulated ICN1 cells with exogenous
IL-12 and IL-18 and demonstrated a 2-fold lower
IFN-g production (eGFP1 28.6% 6 6% versus
ICN1 11 6 5%, n5 3, P5 .05; Figure 4B). Superna-
tants collected form ICN1 cells at the end of culture
showed 10-fold lower concentrations of monocyte
chemoattractant protein 1 (CCL2 [MCP-1], n 5 5;
P 5 .01) and CXCL8 (IL-8, n 5 5, P 5 .004)
(Figure 4C), suggesting a pattern of immaturity. In
Figure 3. Notch1 enhances early NK cell commitment from CD341 UCB precursors. EL08-1D2 stroma and cytokine (Flt3-L, IL-7, c-kit-L, IL-15, and
IL-3) cultured cells were harvested, counted, and analyzed by flow cytometry. (A) Absolute numbers of cultured eGFP1(:) and ICN1(:)-derived
CD561CD32 NK cells calculated per 100 plated cells were compared at weekly intervals. In the presence of stroma, activated Notch1 conferred
an early growth advantage to cultured cells compared to eGFP1 control cells (:) at days 14 and 21 (*P 5 .005; mean of 3 independent experiments
shown). (B) Stroma cultured eGFP1 cells and ICN1 cells were harvested at day 28 and compared for expression of CD56 and CD7 (gated on
CD561CD32 cells). CD7 was highly expressed only on ICN1 cells (representative of 6 experiments shown).
188 Biol Blood Marrow Transplant 15:183-194, 2008V. Bachanova et al.contrast, following PMA/ionomycin stimulation,
CD341ICN1-derived NK cells secreted 90 times
higher levels of IL-13 (P 5 .04) and modestly incr-
eased concentrations of TNF-a and GM-CSF, all
characteristic of immature NK cells [36,37].
NKcellmaturation is dependent upon coordinated
acquisition of both activating and inhibitory cell sur-
face receptors that equip NK cells with the capability
to recognize and lyse targets based upon HLA class I
mismatch [38]. C-lectin receptors (NKG2A/CD94,
NKG2C/CD94,NKG2D,CD161), natural cytotoxic-
ity receptors (NKp30, NKp44, NKp46), and KIR have
heterogeneous expression on individual NK cells. We
have previously shown that NK cells differentiation
on murine EL08-1D2 stroma supports the acquisitionof KIR on NK cells only after CD56 expression [15].
The expression of a full array of inhibitory receptors
such asKIR andNKG2A receptorswas virtually absent
from CD341ICN1-derived NK cells compared to
control conditions even when cultures were extended
out to 5 weeks (Figure 5A and B). The proportion of
NK cells positive for the activating receptors
NKG2D and NKp46 was slightly reduced, whereas
there was no change in NKp30 and NKp44 expression
(Figure 5B). Expression of the IL7-Ra receptor
(CD127) was low and not different between popula-
tions, which was confirmed by Q-RT-PCR. CD16,
responsible for antibody-dependent cytotoxicity, was
not expressed by NK cells derived from ICN1 nor
eGFP1 progenitors (data not shown).
Figure 4. CD341ICN1-derived NK cells are hyporesponsive and exhibit immature function. (A) ICN1 and eGFP1-derived cells were cultured with
EL08-1D2 stroma and cytokines (Flt3-L, IL-7, c-kit-L, IL-15, and IL-3). Stroma cultured CD341-derived cells were harvested at day 28 and compared in
51Cr release cytotoxicity assay against K562 targets at various E:Tratio as shown. ICN1-derived cells (:) showed a significant reduction in cytotoxicity
compared to eGFP1 cells (C) (mean of 7 independent experiment6 SEM shown; *P\.05). (B) Cultured CD341ICN1 and CD341eGFP1 cells were
harvested at day 28 and suspended in concentration 1  106 cells/mL. Interferon-g production was analyzed by intracellular stain following stimulation
with IL-12 (10 ng/mL) and IL-18 (100 ng/mL) for 18 hours, followed by Brefeldin A in the last 5 hours of the incubation and permeabilization using cytofix/
cytoperm (4 independent experiments 6 SEM; *P\.05). (C) Chemokines and cytokines were measured by Luminex from eGFP1 and ICN1 cell-free
supernatants prepared after stimulation of 106 cells/well with PMA/ionomycin. Significant differences between eGFP1 (,) and ICN1 (-) cell-free
supernatants were seen for IL-13, GM-CSF, and CCL2 (MCP-1) and IL-2 (mean of 5 independent experiments with SEM is shown; *P\.05).
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for IL-15 in Stromal-Based NK Cell
Development Cultures
To understand the role of IL-15 on NK cell com-
mitment and receptor acquisition, we compared NK
cells derived from stroma cultures supplemented
with and without IL-15. In the absence of IL-15, virtu-
ally no NK cells developed after 28 days from
CD341eGFP1 progenitors compared to 53% 6
12% (n5 3) NK cells derived fromCD341ICN1 cells
(Figure 5C), showing the lack of dependence on IL-15
for NK cell development when signals from both
EL08-1D2 stroma and activated Notch1 are present.
These NK cells did not express NKG2A (Figure 5C)
or KIR. Cultures with IL-15 not only allowed NK
cell commitment from CD341eGFP1 progenitors,
but also stimulated the expression of inhibitory recep-
tors such as NKG2A. However, NKG2A was
expressed to a lesser degree on ICN1-derivedNK cells
(Figure 5C).
Notch1 and IL-15 Can Replace Stroma
in Supporting NK Cell Commitment
Under stroma-free conditions supplemented with
human cytokines including IL-15, CD341eGFP1 cells
were unable todevelop intoNKcells (Figure 6AandB).In contrast, CD341ICN1 progenitors proliferated and
differentiated along the NK lineage (Figure 6A and B).
These NK cells showed low to absent expression of in-
hibitory receptors NKG2A (Figure 6B) and KIR, but
did exhibit a low capacity to kill K562 targets (not
shown). Functionally, stroma-free ICN1-derived NK
cells produced high levels of IL-13 andMCP-1, and se-
creted low levels of IL-8, characteristics similar to NK
cells derived from EL08-1D2 cultured CD341ICN1
progenitors. In the absence of stroma, these ICN1-de-
rived CD561 NK cells were CD117high and CD942
cells (Figure 6B), suggesting a block in NK cell differ-
entiation.Generation of IL2 Producing cyCD31Cells from
Human CD341ICN1 Progenitors
CD3 expression was next examined on the progeny
of CD341ICN1 cells cocultured with and without
EL08-1D2 stroma. In the presence of stroma signals
and activatedNotch, we observed a distinct population
of cells expressing cytoplasmic CD3, whereas essen-
tially no CD3 was seen in stroma-free conditions and
eGFP control-derivedNK cells (cyCD31cells: eGFP1
1.6% 6 0.26% versus ICN1 21% 6 3.9%, n 5 5,
P\ .01) Figure 7A. Expression of CD3 did not change
with prolonged culture and cells did not express
Figure 5. Expression of NK cell receptors is altered by activated Notch. (A) Representative histograms of NK cell receptors on NK cells derived from
CD341eGFP1 and CD341ICN1 cells coculured with EL08-1D2 stroma and cytokines (Flt3-L, IL-7, c-kit-L, IL-15, and IL-3) are shown (gated on
CD561CD3- cells). ICN1 NK cells demonstrated less NKG2A and KIR expression. (B) Bars represent the average expression of receptors on
CD561CD32 NK cells derived from stroma cultured CD341eGFP1 (,) and CD341ICN1 (-) at day 28 (mean of 4 independent experiments 6
SEM). (C) CD341eGFP1 and CD341ICN1 cells were cultured for 28 days on EL08-1D2 with Flt3-L, IL-7, c-kit-L, and IL-3 with and without IL-15.
In the absence of IL-15, only CD341ICN1 population gave rise to NK cells. NKG2A expression on CD341ICN1-derived NK cells is compared to
eGFP-derived NK cells with and without IL-15.
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negative for CD4, CD8, and positive for high-affinity
IL-2 receptor (CD25). Following stimulation with
PMA/Ionomycin, 62%6 4% of ICN1CD31 cells ex-
pressed intracellular IL-2 compared to 1.6% 6 1% in
eGFP1 control cells (Figure 7A). We confirmed these
results by showing a 100-fold increase in IL-2 in super-
natants of Notch1 transduced cells (Figure 4C). Pre-
T-alpha, RAG-1, RAG-2, GATA-3, and particularly
CD3 gamma chain, CD3 delta chain, and CD3 epsilon
chain transcripts were upregulated by Q-RT-PCR in
CD341ICN1-derived cells compared to controls
(Figure 7B), all consistent with the presence of a popu-
lation capable of T-lineage commitment.DISCUSSION
NK cell development proceeds through an orderly
sequenceofmaturational stagesgovernedbysignalspro-
vided by a supportive microenvironment [32,33]. Using
an approach where Notch is constitutively activated, we
found that Notch1 signaling results in brisk acquisition
of the CD7 antigen resulting in a bipotent CD71 lym-
phoid precursor, brightly expressing CD45RA1 and
CD62L1 receptors capable ofNKcell lineage commit-ment. Lymph node homing requires CD62L (L-selec-
tin) expression to interact with high endothelial venules
[37], and the cells we find after Notch stimulation bear
some similarities to early NK cell precursors described
in lymph nodes by Caligiuri’s group [8].
Results are consistentwith prior studies [21-23] de-
scribing a link betweenNotch signaling and a common
T/NK lymphoid precursor. Our study extends those
observations by showing that Notch1 can fully replace
the requirement for stroma in NK cell differentiation
from cord blood CD341 progenitors. Furthermore,
Notch1 combined with signals from EL08-1D2
stroma supports NK cell differentiation even in the ab-
sence of IL-15. These findings are important as we bet-
ter understand the separation of signals governing NK
commitment and those important for NK activation.
Once CD34 is lost, Notch1 continues to enhance
NK and T cell commitment but does not allow full
maturation in our model. Sustained Notch1 activation
results in a relative block in development as seen in
both functional and phenotypic analyses. For example,
the pattern of CD117highCD942 expression of ICN1-
derived NK cells is consistent with a block in NK cell
development as described by Grzywacz et al. [32].
The pattern of cytokine and chemokine secretion is
Figure 6. Notch 1 can replace stroma in supporting NK cell commitment from CD341UCB progenitors. (A) NK cells derived from CD341eGFP1 and
CD341ICN1 progenitors were cultured without stroma but with cytokines (Flt3-L, IL-7, c-kit-L, IL-15, and IL-3). Absolute numbers of cultured eGFP1
(A) and ICN1 (:)-derived CD561CD32 NK cells are shown. Only CD341ICN1 cells were able to expand without stroma (mean of 3 independent
experiments shown). (B) The phenotype of CD341ICN1-derived stroma-free cultured NK cells at day 28 is shown, which indicates the accumulation of
CD561CD117high CD94lo NKG2Alocells.
Biol Blood Marrow Transplant 15:183-194, 2008 191Notch in Human NK Cell Developmentconsistent with immature NK cells and fetal NK cells,
especially the IL-13 secretion [36,37]. Immaturity is
supported further by their diminished ability to kill tar-
gets and their altered phenotype, particularly reduced
KIR and NKG2A expression. Lack of KIR expression
is associated with functional immaturity [43] and
a more primitive stage in NK cell ontogeny [11]. In
accordance with our findings, the lack of mouse Ly49
receptors (KIR counterparts) was reported in NK cells
that develop from Pax52/2 proB cells exposed to
Notch signaling [23]. In the human system, Cooley
et al. [5] has described KIR acquisition as the sixth
and final stage in NK cell development, different
from stage 5 CD56dim cells, which do not express
KIR and exhibit diminished function, much like the
Notch1 transduced cells described here. Although
the exact mechanism of KIR acquisition is poorly un-
derstood, it is possible that Notch plays a role in this
process and needs to be turned off to allow NK matu-
ration. This possibility needs further study.
We showed that expression of CD62L, CD45RA,
and cytoplasmic CD3 (cyCD3) was dependent on both
Notch and stromal signals, which act as important
cofactors in this process. The cyCD3 expression
(e, z, g, and d) reported here is consistent with the find-
ing thatWnt3a, possible stimulated by stromal signals,
can modulate Notch signaling [39]. Our results are
consistent with the studies by De Smedt et al., whoshow that the addition of Wnt to the Notch ligand
Delta 1 dramatically increased expression of cyCD3e
and Wnt inhibition promoted NK cell lineage differ-
entiation. Our cyCD31 cells are capable of IL-2 pro-
duction following PMA stimulation, suggesting that
they already exhibit some T cell function despite the
fact that they are phenotypically immature. Because
NK cells do not produce IL-2, thematuration stage in-
duced in these IL-2 producing cells is consistent with
the notion that pre-T cells are developing but are
too immature to express surface CD3 and TCR [44].
Stroma-derived factors provide signals in the de-
velopmental link between NK cells and T cells, and
there are several lines of evidence that differences in
stroma dramatically modify Notch signaling [45-47].
The Notch pathway is tightly regulated by restrictive
expression of Delta and Jagged ligands in different mi-
croenvironments, which provide signal timing and
strength to determine cell fate. The essential and non-
redundant role of Delta 1 ligand in the T cell commit-
ment was shown in thymic cultures on OP9-DLL1
stroma [48]. In vitro cultures using Jagged11OP9
stroma showed that the differentiation of immature
thymocytes was biased toward the NK cell lineage
and promoted development of rare gd 1 T cells, con-
sistent with the known high expression of Jagged 1 in
bone marrow stroma [21]. In addition, the use of the
Notch cleavage g-secretase inhibitor impaired
Figure 7. Activated Notch induced a generation of cyCD31 lymphocytes capable of producing IL-2. UCB CD341 progenitors transduced with GFP
and ICN were cultured and analyzed at day 28. (A) ICN1 or eGFP1-derived cells were incubated in the presence of phorbol ester and calcium ionophore
(PMA/ionomycin) for 5 hours. Brefeldin A was added to cultures and cells were permeabilized using cytofix/cytoperm. Representative flow cytometry
plots for expression of CD56 and cytoplasmic CD3 (cyCD3) are shown (left panel). The cyCD31ICN1 population was capable of IL-2 production after
PMA stimulation (right panel, representative of 4 independent experiments). (B) RNA transcripts of RAG1, RAG2, pre-Ta, GATA3, cyCD3 g, d, e, zeta
were analyzed by QRT-PCR and compared between ICN1 and eGFP-derived cells harvested at day 28. The induction of specific mRNA is relative to the
level of GAPDH expression and is normalized to the ratio of eGFP-derived NK cells. Bars represent the average of 3 independent experiments6 SEM.
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manner and favored B cell, NK-cell, and monocytic/
dendritic-cell differentiation.
We propose that local NK cell differentiation
could be influenced by the close physical proximity
of lymphoid precursors and the local and specific tissue
expression of Notch ligands. Besides the microenvi-
ronment of bone marrow, the milieu of extramedullary
tissues such as lymph nodes or fetal thymus may be
permissible to NK development. Recently, Di Santo
and colleagues [40,41] have shown the existence of
a thymic NK cell developmental pathway in the
mouse, defined by high expression of CD127 and de-
pendency on GATA-3. However, Notch-derived NK
cells described here failed to express CD127 at high
levels, although Gata-3 transcripts, a direct down-
streamNotch target, were increased. Another example
of extramedullary microenvironment specific lym-
phoid development is found in gastrointestinal mu-
cosa, where extensive expression of Notch and their
ligands are found [42]. The human small intestine is
a site of CD341CD71 lymphoid precursor develop-
ment, not generally present in the circulation, suggest-ing that the gut may be an important site of early
lymphoid differentiation [49]. These findings support
the notion that Notch ligand expressing tissues play
a role in NK cell differentiation and ultimately in the
process of NK cell education.
In summary, our data support a vital role of Notch
signaling in early stages of NK cell development. The
NK cells derived from Notch1 activated CD341 pro-
genitors resemble the phenotype of immature CD56
cells that develop in lymphoid tissues. Like these cells,
Notch-activated cells are functionally hyporesponsive.
This is consistent with a model that Notch is physio-
logically regulated in extramedually lymphoid tissue
by the quality and quantity of the local and specific
expression of Notch ligands.ACKNOWLEDGMENTS
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